Arylmethylene hydrazine derivatives containing 1,3-dimethylbarbituric moiety as novel urease inhibitors

Abstract A new series of arylmethylene hydrazine derivatives bearing 1,3-dimethylbarbituric moiety 7a–o were designed, synthesized, and evaluated for their in vitro urease inhibitory activity. All the title compounds displayed high anti-urease activity, with IC50 values in the range of 0.61 ± 0.06–4...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Keyvan Pedrood, Homa Azizian, Mohammad Nazari Montazer, Maryam Mohammadi‐Khanaposhtani, Mohammad Sadegh Asgari, Mehdi Asadi, Saeed Bahadorikhalili, Hossein Rastegar, Bagher Larijani, Massoud Amanlou, Mohammad Mahdavi
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2021
Materias:	Medicine R Science Q
Acceso en línea:	https://doaj.org/article/532fe090754145b8a11fda665c0b10b4
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:532fe090754145b8a11fda665c0b10b4
record_format	dspace
spelling	oai:doaj.org-article:532fe090754145b8a11fda665c0b10b42021-12-02T15:45:21ZArylmethylene hydrazine derivatives containing 1,3-dimethylbarbituric moiety as novel urease inhibitors10.1038/s41598-021-90104-x2045-2322https://doaj.org/article/532fe090754145b8a11fda665c0b10b42021-05-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-90104-xhttps://doaj.org/toc/2045-2322Abstract A new series of arylmethylene hydrazine derivatives bearing 1,3-dimethylbarbituric moiety 7a–o were designed, synthesized, and evaluated for their in vitro urease inhibitory activity. All the title compounds displayed high anti-urease activity, with IC50 values in the range of 0.61 ± 0.06–4.56 ± 0.18 µM as compared to the two standard inhibitors hydroxyurea (IC50 = 100 ± 0.15 μM) and thiourea (IC50 = 23 ± 1.7 μM). Among the synthesized compounds, compound 7h with 2-nitro benzylidene group was found to be the most potent compound. Kinetic study of this compound revealed that it is a mix-mode inhibitor against urease. Evaluation of the interaction modes of the synthesized compounds in urease active site by molecular modeling revealed that that compounds with higher urease inhibitor activity (7h, 7m, 7c, 7l, 7i, and 7o, with IC50 of 0.61, 0.86, 1.2, 1.34, 1.33, 1.94 μM, respectively) could interact with higher number of residues, specially Arg609, Cys592 (as part of urease active site flap) and showed higher computed free energy, while compounds with lower urease activity (7f, 7n, 7g, and 7a with IC50 of 3.56, 4.56, 3.62 and 4.43 μM, respectively) and could not provide the proper interaction with Arg609, and Cys592 as the key interacting residues along with lower free binding energy. MD investigation revealed compound 7h interacted with Arg609 and Cys592 which are of the key residues at the root part of mobile flap covering the active site. Interacting with the mentioned residue for a significant amount of time, affects the flexibility of the mobile flap covering the active site and causes inhibition of the ureolytic activity. Furthermore, in silico physico-chemical study of compounds 7a–o predicted that all these compounds are drug-likeness with considerable orally availability.Keyvan PedroodHoma AzizianMohammad Nazari MontazerMaryam Mohammadi‐KhanaposhtaniMohammad Sadegh AsgariMehdi AsadiSaeed BahadorikhaliliHossein RastegarBagher LarijaniMassoud AmanlouMohammad MahdaviNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-16 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine R Science Q
spellingShingle	Medicine R Science Q Keyvan Pedrood Homa Azizian Mohammad Nazari Montazer Maryam Mohammadi‐Khanaposhtani Mohammad Sadegh Asgari Mehdi Asadi Saeed Bahadorikhalili Hossein Rastegar Bagher Larijani Massoud Amanlou Mohammad Mahdavi Arylmethylene hydrazine derivatives containing 1,3-dimethylbarbituric moiety as novel urease inhibitors
description	Abstract A new series of arylmethylene hydrazine derivatives bearing 1,3-dimethylbarbituric moiety 7a–o were designed, synthesized, and evaluated for their in vitro urease inhibitory activity. All the title compounds displayed high anti-urease activity, with IC50 values in the range of 0.61 ± 0.06–4.56 ± 0.18 µM as compared to the two standard inhibitors hydroxyurea (IC50 = 100 ± 0.15 μM) and thiourea (IC50 = 23 ± 1.7 μM). Among the synthesized compounds, compound 7h with 2-nitro benzylidene group was found to be the most potent compound. Kinetic study of this compound revealed that it is a mix-mode inhibitor against urease. Evaluation of the interaction modes of the synthesized compounds in urease active site by molecular modeling revealed that that compounds with higher urease inhibitor activity (7h, 7m, 7c, 7l, 7i, and 7o, with IC50 of 0.61, 0.86, 1.2, 1.34, 1.33, 1.94 μM, respectively) could interact with higher number of residues, specially Arg609, Cys592 (as part of urease active site flap) and showed higher computed free energy, while compounds with lower urease activity (7f, 7n, 7g, and 7a with IC50 of 3.56, 4.56, 3.62 and 4.43 μM, respectively) and could not provide the proper interaction with Arg609, and Cys592 as the key interacting residues along with lower free binding energy. MD investigation revealed compound 7h interacted with Arg609 and Cys592 which are of the key residues at the root part of mobile flap covering the active site. Interacting with the mentioned residue for a significant amount of time, affects the flexibility of the mobile flap covering the active site and causes inhibition of the ureolytic activity. Furthermore, in silico physico-chemical study of compounds 7a–o predicted that all these compounds are drug-likeness with considerable orally availability.
format	article
author	Keyvan Pedrood Homa Azizian Mohammad Nazari Montazer Maryam Mohammadi‐Khanaposhtani Mohammad Sadegh Asgari Mehdi Asadi Saeed Bahadorikhalili Hossein Rastegar Bagher Larijani Massoud Amanlou Mohammad Mahdavi
author_facet	Keyvan Pedrood Homa Azizian Mohammad Nazari Montazer Maryam Mohammadi‐Khanaposhtani Mohammad Sadegh Asgari Mehdi Asadi Saeed Bahadorikhalili Hossein Rastegar Bagher Larijani Massoud Amanlou Mohammad Mahdavi
author_sort	Keyvan Pedrood
title	Arylmethylene hydrazine derivatives containing 1,3-dimethylbarbituric moiety as novel urease inhibitors
title_short	Arylmethylene hydrazine derivatives containing 1,3-dimethylbarbituric moiety as novel urease inhibitors
title_full	Arylmethylene hydrazine derivatives containing 1,3-dimethylbarbituric moiety as novel urease inhibitors
title_fullStr	Arylmethylene hydrazine derivatives containing 1,3-dimethylbarbituric moiety as novel urease inhibitors
title_full_unstemmed	Arylmethylene hydrazine derivatives containing 1,3-dimethylbarbituric moiety as novel urease inhibitors
title_sort	arylmethylene hydrazine derivatives containing 1,3-dimethylbarbituric moiety as novel urease inhibitors
publisher	Nature Portfolio
publishDate	2021
url	https://doaj.org/article/532fe090754145b8a11fda665c0b10b4
work_keys_str_mv	AT keyvanpedrood arylmethylenehydrazinederivativescontaining13dimethylbarbituricmoietyasnovelureaseinhibitors AT homaazizian arylmethylenehydrazinederivativescontaining13dimethylbarbituricmoietyasnovelureaseinhibitors AT mohammadnazarimontazer arylmethylenehydrazinederivativescontaining13dimethylbarbituricmoietyasnovelureaseinhibitors AT maryammohammadikhanaposhtani arylmethylenehydrazinederivativescontaining13dimethylbarbituricmoietyasnovelureaseinhibitors AT mohammadsadeghasgari arylmethylenehydrazinederivativescontaining13dimethylbarbituricmoietyasnovelureaseinhibitors AT mehdiasadi arylmethylenehydrazinederivativescontaining13dimethylbarbituricmoietyasnovelureaseinhibitors AT saeedbahadorikhalili arylmethylenehydrazinederivativescontaining13dimethylbarbituricmoietyasnovelureaseinhibitors AT hosseinrastegar arylmethylenehydrazinederivativescontaining13dimethylbarbituricmoietyasnovelureaseinhibitors AT bagherlarijani arylmethylenehydrazinederivativescontaining13dimethylbarbituricmoietyasnovelureaseinhibitors AT massoudamanlou arylmethylenehydrazinederivativescontaining13dimethylbarbituricmoietyasnovelureaseinhibitors AT mohammadmahdavi arylmethylenehydrazinederivativescontaining13dimethylbarbituricmoietyasnovelureaseinhibitors
_version_	1718385749223538688

Arylmethylene hydrazine derivatives containing 1,3-dimethylbarbituric moiety as novel urease inhibitors

Ejemplares similares